Quick Answer
EUDA Health Holdings Ltd reported Cash and Equivalents of $189.0 thousand for fiscal year 2023.
EUDA Health Holdings Ltd Cash and Equivalents — Annual History
| Fiscal Year | Cash and Equivalents | YoY Change |
|---|---|---|
| 2023 | $189.0K | +228.5% |
| 2022 | $57.5K | -70.3% |
| 2022 | $193.5K | +1.9% |
| 2021 | $190.0K | — |
Quarterly Cash and Equivalents
| Quarter Ending | Cash and Equivalents | YoY | QoQ |
|---|---|---|---|
| March 31, 2023 | $837.3K | — | +485.4% |
| December 31, 2022 | $143.0K | — | -46.2% |
| October 31, 2022 | $265.9K | — | +37.4% |
| July 31, 2022 | $193.5K | — | -64.6% |
| April 30, 2022 | $546.9K | — | -6.9% |
| January 31, 2022 | $587.4K | — | — |
- EUDA Health Holdings Ltd showed an increase of +228.5% in Cash and Equivalents compared to the prior fiscal year.
- Over the 2021–2023 period, EUDA Health Holdings Ltd’s cash and equivalents has declined by 0.5% (from $190.0 thousand to $189.0 thousand).
- The most recent figure is from EUDA Health Holdings Ltd’s fiscal year 2023 report (Form 20-F), filed with the SEC on May 9, 2024.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: